WealthPLAN Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5	Closed	-$281	–	468
2023 Q2	$281	Hold	5	–	–	﹤0.01%	1202
2023 Q1	$226	Sell	5 -7,922	-100%	-$358K	﹤0.01%	1275
2022 Q4	$403K	Buy	+7,927	New	+$403K	0.03%	280
2022 Q1	$382K	Buy	+7,699	New	+$382K	0.03%	280